Company Profile


Shin Nippon Biomedical Laboratories (SNBL Japan), was founded in Kagoshima as Japan’s first contract research organization in 1957.

 

Since then, SNBL has steadily expanded and innovated to become a global business that works in the pre-clinical research, clinical pharmacology research, pharmacokinetics and analysis, clinical trial, site management organization (SMO), and other industries.

In recent years, we have built strong partnerships based on our corporate philosophy, including with our translational research business partner.

 

SNBL is striving toward globalization and expanded from Japan into North America, Europe, and other parts of Asia.

 

"At SNBL Group we are all committed to freeing patients from suffering, by supporting drug development and improving medical technology."

 

SNBL Group leverages its considerable experience and continues to provide service that is highly regarded for its responsiveness and high quality. We aim to surpass the expectations of all stakeholders.

 

Company name

Shin Nihon Kagaku, Ltd. (株式会社新日本科学)

English Company name

Shin Nippon Biomedical Laboratories, Ltd. (SNBL)

Established

September 16, 1957

Representative

Representative Chairman, President & CEO Ryoichi Nagata

Capital

9billion 679million 70thousand 400 yen (as of March 31, 2021)

Employees

Shin Nippon Biomedical Laboratories

965 employees

(Including 747 full-time employees)

SNBL Group

2,111 employees

(Including those of equity method affiliates, etc.)

as of March 2021

Type of Business

CRO business: preclinical and clinical studies
Translational Research business: R&D and drug discovery based on intranasal drug delivery platform 
Medipolis business: geothermal power generation and hospitality 

Main Banks

Kagoshima Bank, Mizuho Bank, Bank of Tokyo-Mitsubishi UFJ, Shoko Chukin Bank

Subsidiaries and Affiliates 

Shin Nippon Biomedical Laboratories, Ltd. (SNBL)

Clinical Study Support, Ltd.

SNBL U.S.A., Ltd.

University Medicines International, LLC.

Shin Nippon Biomedical Laboratories (Asia) Limited

Shin Nippon Biomedical Laboratories (Cambodia) Limited

Angkor Primates Center Inc.
Tian Hu (Cambodia) Animal Breeding Research Center Ltd.

PPD-SNBL K.K.

SNBL China (肇慶創薬生物科技有限公司)

Gemseki Inc.

AXIS, Inc.

SNLD Ltd.

Ruika Therapeutics, Inc.

AMAFURU&Co Ltd.

Medipolis Energy Ltd.

Green Hydrogen Ltd.

Shin Nippon Biomedical Laboratories Group, K.K.
Medipolis K. K.
SNBL Asset Management Co., Ltd.

Fureai Sasaeai Co., Ltd.
Bhutan Fortune Ltd.
Trunk Solution Corp.

IKO Health Technologies Corp.

Shirao Corporation

Taniyama Radio Service Ltd.

Freesia HD, Inc.

J RMPC K.K.

NANA K.K.
(as of December 31,  2021